Net profit of Trident Texofab rose 13.00% to Rs 1.13 crore in the quarter ended September 2025 as against Rs 1.00 crore during the previous quarter ended September 2024. Sales rose 15.80% to Rs 30.63 crore in the quarter ended September 2025 as against Rs 26.45 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales30.6326.45 16 OPM %8.13-1.06 - PBDT1.921.35 42 PBT1.510.94 61 NP1.131.00 13 Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Trident Texofab announced that the 17th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News

Net profit of Trident Texofab rose 45.71% to Rs 1.02 crore in the quarter ended June 2025 as against Rs 0.70 crore during the previous quarter ended June 2024. Sales rose 9.22% to Rs 28.08 crore in the quarter ended June 2025 as against Rs 25.71 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales28.0825.71 9 OPM %7.375.95 - PBDT1.781.34 33 PBT1.370.93 47 NP1.020.70 46 Powered by Capital Market - Live News

Trident Texofab has revised the meeting of the Board of Directors which was scheduled to be held on 12 August 2025. The meeting will now be held on 13 August 2025.Powered by Capital Market - Live News